MSB 7.69% $1.19 mesoblast limited

FDA ODAC Meeting Material discussion analysis, page-308

  1. 116 Posts.
    lightbulb Created with Sketch. 12
    Yeah, can't see how they can say its effective, durable, has no safety concerns and these sick kids have no other option, but because we don't understand how it works we will not approve.

    Surely they will approve and request a phase 4 confirmatory trial to try and understand the MoA a bit better.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.